TOP STORIES

• ORGANIZATION NHO to Review Calculation Method for Clinical Trial Costs
  December 28, 2012

• REGULATORY 2nd Abe Cabinet Inaugurated; Industry Awaits Decision on Perpetuation of Premium for New Drug Development
  December 27, 2012

• REGULATORY LDP to Finalize Tax Reform Outline for FY2013 by Late January
  December 26, 2012

• ORGANIZATION JMA to Discuss JPMA’s Transparency Guidelines with JPMA, Related Medical Organizations
  December 25, 2012

• REGULATORY MHLW to Establish a Venue for Discussions to Review Policies for OTC Switching of Lifestyle Disease Treatments
  December 21, 2012

• REGULATORY Osaka’s Healthcare Plan Highlights Differences in Definition of “Frequent Deliveries”
  December 21, 2012

• REGULATORY CSIMC Recommends New Rules on Reducing Prices of Long-Listed Drugs
  December 21, 2012

• REGULATORY MHLW to Revise and Consider Legislation of Ethical Guidelines for Clinical Research
  December 20, 2012

• REGULATORY Pharmaceutical Industry Welcomes Incoming Abe Administration
  December 19, 2012

• BUSINESS Takeda Faces Generic Entry for Candesartan in US
  December 18, 2012

• BUSINESS Pfizer Specialty Care Chief Hopeful about Japan Vaccine Market, Novel RA Treatment
  December 17, 2012

• BUSINESS Elmed Eisai, Kobayashi Kako Get Their Allegra Generics Listed
  December 14, 2012

• BUSINESS Zydus to Build New Plant in India for Japan-Bound Generics
  December 13, 2012

• REGULATORY Strategy Council Proposes Revamped Framework to Oversee Entire Life Innovation Budgets
  December 12, 2012

• BUSINESS Mochida Revving Up Collaboration Efforts in Biosimilars
  December 11, 2012

• REGULATORY Long-Listed Products Not Granted Premium Should Be Exempted from New Rule: FPMAJ’s Kamoya
  December 10, 2012

• BUSINESS Actavis Eyes 3 Monoclonal Antibodies for Entry into Japanese Biosimilar Market: EVP
  December 10, 2012

• BUSINESS With Spiriva Combination Product in PIII, BI Not Fear Competition in COPD Market: Chairman Barner
  December 7, 2012

• REGULATORY CSIMC Subcommittee Agrees on Introduction of New Price-Cut Rule for Long-Listed Products
  December 6, 2012

• ORGANIZATION Drug Costs Should Be Basically Borne by Patients under Compassionate Use System: JPMA’s Kuwahara
  December 5, 2012

ページ

• « 先頭
• ‹ Prev
• …
• 225
• 226
• 227
• 228
• 229
• 230
• 231
• 232
• 233
• …
• Next ›
• 最終 »